Latest news
from Argenta

View all articles >

AML Riverside is set to supply the United States market

Solid dose and liquid products destined for the US Market and beyond

Auckland pharmaceutical company Argenta expands to the US

14,000 sqm manufacturing facility opens in Fort Dodge, Iowa

Join the team

View all job opportunities >

No other company in the world is quite like ours.

Argenta is dedicated to improving the health of animals worldwide - by researching, developing and manufacturing innovative products for both livestock and companion animals.

Find out more

Meet our people

Overview

Dr Doug Cleverly >
Managing Director & Founder
David Biland >
CEO
Glenn Boyes >
Group Financial Controller
Phil Huse >
General Manager Operations
Bruce Wallace >
Head of Quality
Johnny Jacobsen >
Chief Operating Officer, AlcheraBio

Learn more about our subsidiary, AlcheraBio

As leading veterinary contract research organization (CRO) and animal health consultancy, AlcheraBio is a perfect subsidiary, complimenting Argenta's animal health R&D and manufacturing capabilities.

Find out more